The last decade's progress in demonstrating the clinical benefit of endovascular
thrombectomy (EVT) in patients with large vessel occlusion stroke has transformed the …

Endovascular therapy (EVT) has revolutionized the treatment of acute ischemic stroke. In the
past few years, endovascular treatment indications have expanded to include patients being …

Background Two recent trials demonstrated a benefit for endovascular therapy (EVT) in the
treatment of basilar artery occlusion (BAO). In light of the expected increase in the use of …

Introduction Stroke is one of the main causes of death and disability worldwide.
Nevertheless, despite the global burden of this disease, our understanding is limited and …

OBJECTIVE Concern about thromboembolic events after flow diversion (FD) warrants dual
antiplatelet therapy for 3 to 6 months. Platelet function tests are routinely performed prior to …

Background Mediators, genomic and epigenomic characteristics involving in metabolism of
arachidonic acid by cyclooxygenase (COX) and lipoxygenase (ALOX) and hepatic activation …

Introduction Cerebrovascular disease is a leading cause of morbidity and mortality in the
world and antiplatelet therapy is a main pharmacologic means of secondary prevention …

Coagulopathy refers to an abnormal state of hemostasis. The incidence of coagulopathy in
neurocritical care is described variedly between 14 and 80% and affects the prognosis of …

Background Dual antiplatelet therapy (DAPT) is standard care for intracranial stenting to
prevent thrombotic complications. Clopidogrel resistance has resulted in patients receiving …

Introduction: Dual antiplatelet therapy (DAPT) use is the standard of practice after flow
diversion (FD) for intracranial aneurysms (IAs). Yet, no consensus exists in the literature …